FR2412533B1 - - Google Patents
Info
- Publication number
- FR2412533B1 FR2412533B1 FR7835956A FR7835956A FR2412533B1 FR 2412533 B1 FR2412533 B1 FR 2412533B1 FR 7835956 A FR7835956 A FR 7835956A FR 7835956 A FR7835956 A FR 7835956A FR 2412533 B1 FR2412533 B1 FR 2412533B1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Quinoline Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/863,269 US4251534A (en) | 1977-12-22 | 1977-12-22 | Antihypertensive polyfluorohydroxyisopropyl bicyclic and tricyclic carbostyrils |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2412533A1 FR2412533A1 (fr) | 1979-07-20 |
FR2412533B1 true FR2412533B1 (fr) | 1981-10-02 |
Family
ID=25340730
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7835956A Granted FR2412533A1 (fr) | 1977-12-22 | 1978-12-21 | Polyfluorohydroxyisopropyl carbostyriles bicycliques et tricycliques antihypertensifs, leur preparation et compositions pharmaceutiques les contenant |
Country Status (11)
Country | Link |
---|---|
US (1) | US4251534A (fr) |
JP (1) | JPS5498780A (fr) |
BE (1) | BE872956A (fr) |
CA (1) | CA1099712A (fr) |
DE (1) | DE2854727A1 (fr) |
DK (1) | DK574978A (fr) |
FR (1) | FR2412533A1 (fr) |
GB (1) | GB2010821B (fr) |
IT (1) | IT1102419B (fr) |
LU (1) | LU80720A1 (fr) |
NL (1) | NL7812422A (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4499108A (en) * | 1983-06-08 | 1985-02-12 | Schering Corporation | Stable pleasant-tasting albuterol sulfate pharmaceutical formulations |
US5622965A (en) * | 1993-03-12 | 1997-04-22 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon | 4-hydroxy-3-nitro-1,2-dihydroquinolin-2-ones and the use thereof as excitatory amino acid and glycine receptor antagonists |
US6316503B1 (en) | 1999-03-15 | 2001-11-13 | Tularik Inc. | LXR modulators |
US7112606B2 (en) * | 2002-01-30 | 2006-09-26 | Amgen Inc. | Heterocyclic arylsulfonamidobenzylic compounds |
WO2003063576A2 (fr) * | 2002-01-30 | 2003-08-07 | Tularik Inc. | Composes arylsulfonamidobenzyliques |
AU2004264354A1 (en) * | 2003-08-12 | 2005-02-24 | Amgen Inc. | Arylsulfonamidobenzylic compounds |
GB201721967D0 (en) * | 2017-12-27 | 2018-02-07 | Bp Oil Int | Methods for preparing fuel additives |
GB201721964D0 (en) * | 2017-12-27 | 2018-02-07 | Bp Oil Int | Methods for preparing fuel additives |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR980098A (fr) * | 1948-12-10 | 1951-05-08 | Poignée protectrice à usages ménagers | |
US3178348A (en) * | 1961-02-08 | 1965-04-13 | Norwich Pharma Co | Hypotensive quinolines |
DE1216878B (de) * | 1963-04-02 | 1966-05-18 | Cassella Farbwerke Mainkur Ag | Verfahren zur Herstellung von coronargefaesserweiternden Derivaten des 7-Hydroxy-2-oxo-1, 2-dihydrochinolins |
US4058612A (en) * | 1974-12-02 | 1977-11-15 | Schering Corporation | 6-(Polyhaloisopropyl)quinazoline-2,4-diones |
IE45227B1 (en) * | 1976-06-24 | 1982-07-14 | Du Pont | Carbostyrils |
-
1977
- 1977-12-22 US US05/863,269 patent/US4251534A/en not_active Expired - Lifetime
-
1978
- 1978-12-19 DE DE19782854727 patent/DE2854727A1/de not_active Withdrawn
- 1978-12-20 CA CA318,285A patent/CA1099712A/fr not_active Expired
- 1978-12-21 NL NL7812422A patent/NL7812422A/xx not_active Application Discontinuation
- 1978-12-21 GB GB7849684A patent/GB2010821B/en not_active Expired
- 1978-12-21 FR FR7835956A patent/FR2412533A1/fr active Granted
- 1978-12-21 IT IT31170/78A patent/IT1102419B/it active
- 1978-12-21 DK DK574978A patent/DK574978A/da not_active Application Discontinuation
- 1978-12-21 BE BE192471A patent/BE872956A/fr unknown
- 1978-12-22 JP JP15840178A patent/JPS5498780A/ja active Pending
- 1978-12-22 LU LU80720A patent/LU80720A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
US4251534A (en) | 1981-02-17 |
JPS5498780A (en) | 1979-08-03 |
GB2010821B (en) | 1982-08-11 |
LU80720A1 (fr) | 1980-01-22 |
FR2412533A1 (fr) | 1979-07-20 |
BE872956A (fr) | 1979-06-21 |
IT1102419B (it) | 1985-10-07 |
NL7812422A (nl) | 1979-06-26 |
GB2010821A (en) | 1979-07-04 |
CA1099712A (fr) | 1981-04-21 |
DE2854727A1 (de) | 1979-06-28 |
DK574978A (da) | 1979-06-23 |
IT7831170A0 (it) | 1978-12-21 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |